Abstract
Objective: The aim of the study was to test the hypothesis that endogenous total testosterone (TT) may relate to incidental prostate cancer (iPCA) in patients with lower urinary tract symptoms (LUTS) associated with prostate enlargement undergoing transurethral resection of the prostate (TURP). Methods: The hypothesis was tested in contemporary cohort of patients who underwent TURP because of LUTS due to prostate enlargement after excluding the suspect of PCA. In period running from January 2017 to November 2019, 389 subjects were evaluated. Endogenous testosterone was measured preoperatively between 8:00 and 10:00 o’clock in the morning. Relationships between TT and iPCA were evaluated by statistical methods. Results: Overall, iPCA was detected in 18 cases (4.6%) with clinical stage cT1a or International Society of Urologic Pathology (ISUP) < 2 in 11 patients (61.1%). Endogenous testosterone was inversely associated with age and BMI in the study population but not in the subgroup with iPCA in wholly endogenous TT strongly correlated to both number of chips involved by cancer (Pearson’s correlation coefficient, r = 0.553; p = 0.017) and ISUP > 2 (r = 0.504; p = 0.033). The positive association of endogenous TT with both tumor load and tumor grade was confirmed by the linear regression model with high-regression coefficients for the former (regression coefficient, b = 0.307; 95% confidence interval, 95% CI: 0.062–0.551; and p = 0.017) as for the latter (b = 5.898; 95% CI: 0.546–11.249; and p = 0.033). Conclusions: Preoperative endogenous TT is associated with features of iPCA. The influence of iPCA on endogenous testosterone needs to be addressed by a large multicenter prospective trial.
References
1.
Gravas
S
, Bach
T
, Bachmann
A
, Drake
M
, Gacci
M
, Gratzke
C
, EAU guidelines on management of non-neurogenic male lower urinary tract symptoms (LUTS), incl. Benign Prostatic Obstruction (BPO)
. 2020th ed. Arnhem, The Netherlands
: European Association of Urology Guidelines Office
; 2020
.2.
Mottet
N
, van den Bergh
RCN
, Briers
E
, Bourke
L
, Cornford
P
, De Santis
M
, EAU–ESTRO–ESUR–SIOG guidelines on prostate cancer
. 2020th ed. Arnhem, The Netherlands
: European Association of Urology Guidelines Office
; 2020
.3.
Madersbacher
S
, Sampson
N
, Culig
Z
. Pathophysiology of benign prostatic hyperplasia and benign prostatic enlargement: a mini-review
. Gerontology
. 2019
;65
(5
):458
–64
. .4.
Anastasiadis
E
, van der Meulen
J
, Emberton
M
. Incidental prostate cancer diagnosed following a transurethral resection of the prostate: a national database analysis in England
. J Clin Urol
. 2016
;9
(3
):170
–6
. .5.
Porcaro
AB
, Tafuri
A
, Inverardi
D
, Amigoni
N
, Sebben
M
, Pirozzi
M
, Incidental prostate cancer after transurethral resection of the prostate: analysis of incidence and risk factors in 458 patients
. Minerva Urol Nefrol
. 2020 Jan 29
. Online ahead of print.6.
Wu
FC
, Tajar
A
, Pye
SR
, Silman
AJ
, Finn
JD
, O’Neill
TW
, Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study
. J Clin Endocrinol Metab
. 2008
;93
(7
):2737
–45
. .7.
Porcaro
AB
, de Luyk
N
, Corsi
P
, Sebben
M
, Tafuri
A
, Tamanini
I
, Bilateral lymph node micrometastases and seminal vesicle invasion associated with same clinical predictors in localized prostate cancer
. Tumori
. 2017
;103
(3
):299
–306
. .8.
Porcaro
AB
, De Luyk
N
, Corsi
P
, Sebben
M
, Tafuri
A
, Processali
T
, Association between basal total testosterone levels and tumor upgrading in low and intermediate risk prostate cancer
. Urol Int
. 2017
;99
(2
):215
–21
. .9.
Porcaro
AB
, Petroziello
A
, Brunelli
M
, De Luyk
N
, Cacciamani
G
, Corsi
P
, High testosterone preoperative plasma levels independently predict biopsy gleason score upgrading in men with prostate cancer undergoing radical prostatectomy
. Urol Int
. 2016
;96
(4
):470
–8
. .10.
Salonia
A
, Gallina
A
, Briganti
A
, Abdollah
F
, Suardi
N
, Capitanio
U
, Preoperative hypogonadism is not an independent predictor of high-risk disease in patients undergoing radical prostatectomy
. Cancer
. 2011
;117
(17
):3953
–62
. .11.
Porcaro
AB
, Tafuri
A
, Sebben
M
, Corsi
P
, Pocessali
T
, Pirozzi
M
, Positive association between preoperative total testosterone levels and risk of positive surgical margins by prostate cancer: results in 476 consecutive patients treated only by radical prostatectomy
. Urol Int
. 2018
;101
(1
):38
–46
. .12.
Massengill
JC
, Sun
L
, Moul
JW
, Wu
H
, McLeod
DG
, Amling
C
, Pretreatment total testosterone level predicts pathological stage in patients with localized prostate cancer treated with radical prostatectomy
. J Urol
. 2003
;169
(5
):1670
–5
. .13.
Dai
B
, Qu
Y
, Kong
Y
, Ye
D
, Yao
X
, Zhang
S
, Low pretreatment serum total testosterone is associated with a high incidence of Gleason score 8–10 disease in prostatectomy specimens: data from ethnic Chinese patients with localized prostate cancer
. BJU Int
. 2012 Dec
;110
(11 Pt B
):E667
–72
.14.
Ferro
M
, Lucarelli
G
, Bruzzese
D
, Di Lorenzo
G
, Perdonà
S
, Autorino
R
, Low serum total testosterone level as a predictor of upstaging and upgrading in low-risk prostate cancer patients meeting the inclusion criteria for active surveillance
. Oncotarget
. 2017
;8
(11
):18424
–34
. .15.
Porcaro
AB
, Tafuri
A
, Novella
G
, Sebben
M
, Mariotto
A
, Inverardi
D
, Inverse association of prostatic chronic inflammation among prostate cancer tumor grade groups: retrospective study of 738 consecutive cases elected to a first random biopsy set
. Urol Int
. 2018
;100
(4
):456
–62
. .16.
Andrén
O
, Garmo
H
, Mucci
L
, Andersson
S-O
, Johansson
J-E
, Fall
K
. Incidence and mortality of incidental prostate cancer: a Swedish register-based study
. Br J Cancer
. 2009 Jan 13
;100
(1
):170
–3
.17.
Lu-Yao
GL
, Albertsen
PC
, Moore
DF
, Shih
W
, Lin
Y
, DiPaola
RS
, Outcomes of localized prostate cancer following conservative management
. Jama
. 2009
;302
(11
):1202
–9
. .18.
Lee
LS
, Thiruneelakandasivam
S
, Hong
MK
, Peters
JS
, Warren
A
, Mills
R
, Are transrectal prostate biopsies routinely indicated in patients with incidentally diagnosed prostate cancer following transurethral resection of the prostate for benign disease?
Urol Int
. 2013
;91
(4
):397
–403
. .19.
Klap
J
, Schmid
M
, Loughlin
KR
. The relationship between total testosterone levels and prostate cancer: a review of the continuing controversy
. J Urol
. 2015
;193
(2
):403
–13
. .20.
Lopez
DS
, Advani
S
, Tsilidis
KK
, Wang
R
, Canfield
S
. Endogenous and exogenous testosterone and prostate cancer: decreased-, increased-or null-risk?
Transl Androl Urol
. 2017 Jun
;6
(3
):566
–79
.21.
Loughlin
KR
. The testosterone conundrum: the putative relationship between testosterone levels and prostate cancer
. Urol Oncol
. 2016 Nov
;34
(11
):482.e1
–.e4
.22.
Porcaro
AB
, Petrozziello
A
, Ghimenton
C
, Migliorini
F
, Sava
T
, Caruso
B
, Associations of pretreatment serum total testosterone measurements with pathology-detected Gleason score cancer
. Urol Int
. 2014
;93
(3
):269
–78
. .23.
Tafuri
A
, Sebben
M
, Shakir
A
, Pirozzi
M
, Processali
T
, Rizzetto
R
, Endogenous testosterone mirrors prostate cancer aggressiveness: correlation between basal testosterone serum levels and prostate cancer European Urology Association clinical risk classes in a large cohort of Caucasian patients
. Int Urol Nephrol
. 2020 Jul
:1261
–9
.24.
Porcaro
AB
, Tafuri
A
, Sebben
M
, Processali
T
, Pirozzi
M
, Shakir
A
, Total testosterone density predicts high tumor load and disease reclassification of prostate cancer: results in 144 low-risk patients who underwent radical prostatectomy
. Int Urol Nephrol
. 2019
;51
(12
):2169
–80
. .25.
Porcaro
AB
, Tafuri
A
, Sebben
M
, Processali
T
, Pirozzi
M
, Amigoni
N
, High body mass index predicts multiple prostate cancer lymph node metastases after radical prostatectomy and extended pelvic lymph node dissection
. Asian J Androl
. 2020 May–Jun
;22
(3
):323
–29
. .26.
Tafuri
A
, Amigoni
N
, Rizzetto
R
, Sebben
M
, Shakir
A
, Gozzo
A
, Obesity strongly predicts clinically undetected multiple lymph node metastases in intermediate- and high-risk prostate cancer patients who underwent robot assisted radical prostatectomy and extended lymph node dissection
. Int Urol Nephrol
. 2020
;52
(11
):2097
–105
. .27.
Ferguson
J
, Zincke
H
, Ellison
E
, Bergstrahl
E
, Bostwick
DG
. Decrease of prostatic intraepithelial neoplasia following androgen deprivation therapy in patients with stage T3 carcinoma treated by radical prostatectomy
. Urology
. 1994
;44
(1
):91
–5
. .28.
Brolin
J
, Skoog
L
, Ekman
P
. Immunohistochemistry and biochemistry in detection of androgen, progesterone, and estrogen receptors in benign and malignant human prostatic tissue
. Prostate
. 1992
;20
(4
):281
–95
. .29.
Bonkhoff
H
, Remberger
K
. Widespread distribution of nuclear androgen receptors in the basal cell layer of the normal and hyperplastic human prostate
. Virchows Arch A Pathol Anat Histopathol
. 1993
;422
(1
):35
–8
. .30.
Hobisch
A
, Culig
Z
, Radmayr
C
, Bartsch
G
, Klocker
H
, Hittmair
A
. Distant metastases from prostatic carcinoma express androgen receptor protein
. Cancer Res
. 1995
;55
(14
):3068
–72
.31.
Tafuri
A
, Porcaro
AB
, Shakir
A
, Migliorini
F
, Verratti
V
, Brunelli
M
, Serum testosterone and obesity in prostate cancer biology: a call for health promotion in the ageing male
. Aging Clin Exp Res
. 2020
:1
–3
. .© 2021 S. Karger AG, Basel
2021
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
